Susquehanna Advisors Group’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.95M Buy
241,016
+102,556
+74% +$2.35M 0.09% 60
2026
Q1
$3.05M Sell
138,460
-709,074
-84% -$12.3M 0.1% 61
2025
Q4
$9.99M Buy
847,534
+522,866
+161% +$6.71M 0.17% 57
2025
Q3
$5.14M Buy
324,668
+250,449
+337% +$3.63M 0.08% 75
2025
Q2
$850K Hold
74,219
0.02% 83
2025
Q1
$1M Hold
74,219
0.04% 51
2024
Q4
$1.25M Buy
+74,219
New +$1.44M 0.04% 101

Other funds holding CC

Susquehanna Advisors Group's CC Position: Q2 2026 in Review

Susquehanna Advisors Group increased its Chemours (CC) stake by 74% in Q2 2026, buying an estimated $2.35M and bringing the position to 241,016 shares worth $4.95M. The position accounts for 0.09% of the portfolio, ranked #60.

Susquehanna Advisors Group first reported a position in CC in Q4 2024 and has held it in 7 quarters since. The position peaked at $9.99M in Q4 2025. 471 funds tracked by Wall St. Rank hold CC as of Q2 2026.

  • Susquehanna Advisors Group held 241,016 shares of Chemours worth $4.95M as of Q2 2026.
  • Susquehanna Advisors Group bought 102,556 Chemours shares in Q2 2026, an estimated $2.35M.
  • Chemours made up 0.09% of Susquehanna Advisors Group's portfolio in Q2 2026, its #60 holding.
  • Susquehanna Advisors Group first reported a position in Chemours in Q4 2024 and has held it in 7 quarters since.
  • Susquehanna Advisors Group's Chemours position peaked at $9.99M in Q4 2025.
  • 471 funds tracked by Wall St. Rank held Chemours as of Q2 2026.

Based on Susquehanna Advisors Group's 13F filing for Q2 2026, filed 14 Aug 2026.